Could Valeant Pharmaceuticals Intl Inc. Go to $0?

Many pundits believe Valeant Pharmaceutical Intl Inc. (TSX:VRX)(NYSE:VRX) could be on its way to bankruptcy. Should you be worried?

| More on:
The Motley Fool

Valeant Pharmaceutical Intl Inc. (TSX:VRX)(NYSE:VRX) has been a huge destroyer of wealth for investors who were too high on the hype. Even activist investor Bill Ackman lost his shirt; he kept hanging on to his shares as they plummeted further into the abyss. He stated that he made a “huge mistake” and that he was “deeply and profoundly” sorry for losing billions of dollars for his fund, Pershing Square Holdings Ltd.

It would take an extraordinarily large amount of effort on Ackman’s part to salvage some upside, so he finally threw in the towel after Valeant lost over 95% of its value. There are valuable lessons to be learned from Ackman’s mistake. It’s never a good idea to hang on to shares just because you don’t want to feel the pain of realizing a loss. Sure, Warren Buffett advises that investors “never lose money,” but you’ve got to know when to admit defeat when major issues could destroy the intrinsic value of a stock.

Bill Ackman thought that Valeant was trading at a huge discount to its intrinsic value when it dropped, and it appeared to be because the assets looked to be top notch. Bausch and Lomb is a terrific business and one of the largest manufacturers of contact lenses in the world.

Where did things go wrong?

Sure, the assets were great, but Valeant had to drown in a massive amount of debt to acquire them. The company was on a greedy acquisition spree, and the old management team probably never had value on their minds. They just wanted to drive the stock up in the short term, but at the expense of the long-term fundamentals of the business.

The company is in fire-sale mode as it prepares to liquidate as many non-core assets as it can, so it can meet its debt obligations. There’s still a lot of selling to do, and it’s truly a race against time before the debt matures. Everyone knows Valeant’s story, so potential buyers of Valeant’s assets will have most of the bargaining power. I believe Valeant will be scrambling to sell assets over the next few years, and there won’t be much room for R&D or growth.

The stock is ridiculously cheap right now, but many pundits believe that Valeant could possibly go bankrupt within the next few years. This is a possibility, so investors should take extreme caution when considering owning shares of Valeant right now. On the bright side, Ackman’s followers are already out the stock, so that’s one less negative catalyst that you don’t have to worry about.

CEO Joseph Papa collected a fat $63 million last year as the stock continued to crumble. This move doesn’t make sense to me, and it’s got to be troubling to shareholders who are looking for a rebound. I believe the company’s reputation is permanently tarnished, and it’s going to be a tough road ahead for Valeant.

Valeant is a cheap stock, but don’t be tricked into thinking the company is near a bottom, because you could still end up losing your shirt. If you want to gamble on Valeant, then you should at least know the risks.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

Canadian Dollars
Stock Market

Where to Invest $5,000 in April 2024

Do you have some extra cash to spare? Here are five companies to invest $5,000 in next month.

Read more »

Plane on runway, aircraft
Stocks for Beginners

Up 53% From its 52-Week Low, Is Cargojet Stock Still a Buy?

Cargojet (TSX:CJT) stock is up a whopping 53%, nearing closer to 52-week highs from 52-week lows, so what's next for…

Read more »

Question marks in a pile
Bank Stocks

Should You Buy Canadian Western Bank for its 4.8% Dividend Yield?

Down 35% from all-time highs, Canadian Western Bank offers a tasty dividend yield of 4.8%. Is the TSX bank stock…

Read more »

Gold bars
Metals and Mining Stocks

Why Alamos Gold Jumped 7% on Wednesday

Alamos (TSX:AGI) stock and Argonaut Gold (TSX:AR) surged after the companies announced a friendly acquisition for $325 million.

Read more »

tsx today
Stock Market

TSX Today: Why Record-Breaking Rally Could Extend on Thursday, March 28

The main TSX index closed above the 22,000 level for the first time yesterday and remains on track to post…

Read more »

Nuclear power station cooling tower
Metals and Mining Stocks

If You’d Invested $1,000 in Cameco Stock 5 Years Ago, This Is How Much You’d Have Now

Cameco (TSX:CCO) stock still looks undervalued, despite a 258% rally. Can the uranium miner deliver more capital gains to shareholders?

Read more »

Businessman holding tablet and showing a growing virtual hologram of statistics, graph and chart with arrow up on dark background. Stock market. Business growth, planning and strategy concept
Dividend Stocks

TFSA Magic: Earn Enormous Passive Income That the CRA Can’t Touch

If you're seeking out passive income, with zero taxes involved, then get on board with a TFSA and this portfolio…

Read more »

potted green plant grows up in arrow shape
Stocks for Beginners

3 Growth Stocks I’m Buying in April

These three growth stocks are up in the last year, and that is likely to continue on as we keep…

Read more »